Onconetix, Inc. (ONCO)
0.6586
+0.03
(+5.07%)
USD |
NASDAQ |
Sep 01, 16:00
0.6586
0.00 (0.00%)
After-Hours: 17:26
Onconetix Total Long Term Debt (Quarterly) : 0.0123M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0123M |
| March 31, 2026 | 0.0183M |
| December 31, 2025 | 0.0244M |
| September 30, 2025 | 0.1603M |
| June 30, 2025 | 8.732M |
| March 31, 2025 | 9.760M |
| December 31, 2024 | 13.45M |
| September 30, 2024 | 9.990M |
| June 30, 2024 | 10.27M |
| March 31, 2024 | 10.56M |
| December 31, 2023 | 9.812M |
| September 30, 2023 | 12.92M |
| Date | Value |
|---|---|
| June 30, 2023 | 13.16M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Aprea Therapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |
| Savara, Inc. | 30.11M |